Amphastar Pharmaceuticals News and Activities
Presence
Amphastar Pharmaceuticals is a pharmaceutical company that specializes in the development, manufacturing, and marketing of generic and proprietary injectable, inhalation, and intranasal products. Their target customers are healthcare providers and patients in need of high-quality, affordable medications.
Amphastar Pharmaceuticals products and services overview:
- Generic Injectable Products
- Inhalation Products
- Intranasal Products
Employees: 2,000
Amphastar Pharmaceuticals is one of the...
Amphastar Pharmaceuticals is a company listed under the stock ticker AMPH (US).
Executives
View the org chart displaying its 10 main executives
Most searched biographies at Amphastar Pharmaceuticals
- Jack Zhang, Chief Executive Officer, President, Chief Scientific O...
- Richard Prins, Lead Independent Director
- Gayle Deflin, Director
Create your alert
to follow the executive moves at Amphastar Pharmaceuticals.
Pharmaceuticals
Amphastar Pharmaceuticals has 1,838 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Sanofi (France).
Popular M&A news in Pharmaceuticals
- Supernus Pharmaceuticals has announced the acquisition of Sage Therapeutics (posted on June 16 2025).
- Juvenescence has just announced a $76 Million fundraising (posted on May 22 2025).
- Kincell Bio has just announced a $22 Million fundraising (posted on May 22 2025).
Popular contacts in Pharmaceuticals
News
Press releases by Amphastar Pharmaceuticals
- Media/News | AMPHASTAR
- RSS News Feeds | Amphastar Pharmaceuticals, Inc.
- Amphastar Pharmaceuticals Receives FDA Approval for Atropine Sulfate Injection | Amphastar Pharmaceuticals, Inc.
- Amphastar Pharmaceuticals to Present at the Wells Fargo 2020 Virtual Healthcare Conference | Amphastar Pharmaceuticals, Inc.
- Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2020 | Amphastar Pharmaceuticals, Inc.
- Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6th, 2020 | Amphastar Pharmaceuticals, Inc.
- Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare Conference | Amphastar Pharmaceuticals, Inc.
- Press Releases | Amphastar Pharmaceuticals, Inc.
- Amphastar Pharmaceuticals to Present at the Raymond James Virtual 2020 Human Healthcare Innovation Conference | Amphastar Pharmaceuticals, Inc.
- Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL) Multiple-Dose Vial | Amphastar Pharmaceuticals, Inc.
- View more press releases Close
Social media about Amphastar Pharmaceuticals
- Amphastar Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
- Amphastar Pharmaceuticals on LinkedIn, Twitter & YouTube
